Literature DB >> 24574805

Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding.

Minoru Tomizawa1, Fuminobu Shinozaki1, Rumiko Hasegawa1, Akira Togawa1, Yoshinori Shirai1, Noboru Ichiki1, Yasufumi Motoyoshi1, Takao Sugiyama1, Shigenori Yamamoto1, Makoto Sueishi1.   

Abstract

AIM: To investigate the early upper gastrointestinal endoscopy (endoscopy) significantly reduces mortality resulting from upper gastrointestinal (GI) bleeding.
METHODS: Upper GI bleeding was defined as 1a, 1b, 2a, and 2b according to the Forrest classification. The hemoglobin (Hb), and C-reactive protein (CRP) were examined at around the day of endoscopy and 3 mo prior to endoscopy. The rate of change was calculated as follows: (the result of blood examination on the day of endoscopy - the results of blood examination 3 mo prior to endoscopy)/(results of blood examination 3 mo prior to endoscopy). Receiver operating characteristic curves were created to determine threshold values.
RESULTS: Seventy-nine men and 77 women were enrolled. There were 17 patients with upper GI bleeding: 12 with a gastric ulcer, 3 with a duodenal ulcer, 1 with an acute gastric mucosal lesion, and 1 with gastric cancer. The area under the curve (AUC), threshold, sensitivity, and specificity of Hb around the day of endoscopy were 0.902, 11.7 g/dL, 94.1%, and 77.1%, respectively, while those of CRP were 0.722, 0.5 mg/dL, 70.5%, and 73%, respectively. The AUC, threshold, sensitivity, and specificity of the rate of change of Hb were 0.851, -21.3%, 76.4%, and 82.6%, respectively, while those of CRP were 0.901, 100%, 100%, and 82.5%, respectively.
CONCLUSION: Predictors for upper GI bleeding were Hb < 11.7 g/dL, reduction rate in the Hb > 21.3% and an increase in the CRP > 100%, 3 mo before endoscopy.

Entities:  

Keywords:  Area under curve; Gastrointestinal bleeding; Receiver operating characteristic; Sensitivity; Specificity

Mesh:

Substances:

Year:  2014        PMID: 24574805      PMCID: PMC3921513          DOI: 10.3748/wjg.v20.i5.1311

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Ultrasonography for leukocytosis or elevated C-reactive protein.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  Hepatogastroenterology       Date:  2011 Jul-Aug

Review 2.  The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis.

Authors:  G N Tytgat
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

3.  Can pre-endoscopic assessment predict active upper gastrointestinal bleeding? A retrospective study in patients with symptoms of upper gastrointestinal bleeding outside regular working hours.

Authors:  Arnd Giese; Catharina Grunwald; Jurgen Zieren; Nikolaus J Buchner; Bernhard F Henning
Journal:  Hepatogastroenterology       Date:  2012 Nov-Dec

4.  Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer.

Authors:  S K H Wong; L-M Yu; J Y W Lau; Y-H Lam; A C W Chan; E K W Ng; J J Y Sung; S C S Chung
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

6.  The efficacy of transcatheter arterial embolization as the first-choice treatment after failure of endoscopic hemostasis and endoscopic treatment resistance factors.

Authors:  Takahito Katano; Tsutomu Mizoshita; Kyoji Senoo; Satoshi Sobue; Hiroki Takada; Tomoyuki Sakamoto; Hisato Mochiduki; Takanori Ozeki; Akihisa Kato; Kayoko Matsunami; Kazuyuki Ito; Takashi Joh
Journal:  Dig Endosc       Date:  2012-04-02       Impact factor: 7.559

7.  Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study.

Authors:  G F Longstreth
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

8.  Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers?

Authors:  W Heldwein; J Schreiner; J Pedrazzoli; P Lehnert
Journal:  Endoscopy       Date:  1989-11       Impact factor: 10.093

9.  Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus--a cross-sectional study.

Authors:  Michael W J Boehme; Frank Autschbach; Christian Ell; Ulrich Raeth
Journal:  Hepatogastroenterology       Date:  2007-03

10.  Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan Barkun; Marc Bardou; John K Marshall
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

View more
  15 in total

1.  Laboratory test variables useful for distinguishing upper from lower gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Successful Endoscopic Hemostasis Is a Protective Factor for Rebleeding and Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding.

Authors:  Yong Jae Han; Jae Myung Cha; Jae Hyun Park; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Joung Il Lee
Journal:  Dig Dis Sci       Date:  2016-02-29       Impact factor: 3.199

3.  Patient characteristics with high or low blood urea nitrogen in upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  Change ratio of hemoglobin has predictive value for upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Biomed Rep       Date:  2016-09-08

5.  Characteristics of colorectal cancer diagnosed with screening abdominal ultrasonography.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Kazunori Fugo; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Mol Clin Oncol       Date:  2016-05-11

6.  Detection of gastric cancer using transabdominal ultrasonography is associated with tumor diameter and depth of invasion.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2015-09-01       Impact factor: 2.447

7.  Elevated C-reactive protein level predicts lower gastrointestinal tract bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Biomed Rep       Date:  2016-04-13

8.  A quantitative exploration of gastrointestinal bleeding in intensive care unit patients.

Authors:  Patrick C Eschenfeldt; Chin Hur
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

9.  Prediction model of emergency mortality risk in patients with acute upper gastrointestinal bleeding: a retrospective study.

Authors:  Lan Chen; Han Zheng; Saibin Wang
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

10.  A Novel Easy-to-Use Prediction Scheme for Upper Gastrointestinal Bleeding: Cologne-WATCH (C-WATCH) Risk Score.

Authors:  Vera Hoffmann; Henrik Neubauer; Julia Heinzler; Anna Smarczyk; Martin Hellmich; Andrea Bowe; Fabian Kuetting; Muenevver Demir; Agnes Pelc; Sigrid Schulte; Ullrich Toex; Dirk Nierhoff; Hans-Michael Steffen
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.